CNTA
HEALTHCARECentessa Pharmaceuticals plc
$39.60-0.07 (-0.18%)PRE
Live · NASDAQ · May 8, Close
AI Insight
What's Moving CNTA Today?
No stock-specific AI insight has been generated for CNTA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$10.95$40.26
$39.60
Fundamentals
Market Cap$6.1B
P/E Ratio—
EPS$-1.78
Dividend Yield—
Dividend / Share—
ROE-0.6%
Profit Margin—
Debt / Equity—
Trading
Volume874K
Avg Volume (10D)—
Shares Outstanding154.7M
CNTA News
27 articles- Eli Lilly Sells $9 Billion of Bonds to Fund AcquisitionsYahoo Finance·May 6, 2026
- Update: Market Chatter: Eli Lilly Plans to Sell About $8 Billion of Bonds to Fund AcquisitionsYahoo Finance·May 6, 2026
- Is It Too Late To Consider Centessa Pharmaceuticals (CNTA) After A 191% One Year Surge?Yahoo Finance·May 3, 2026
- Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026GlobeNewswire Inc.·May 1, 2026
- Guggenheim Raises PT on Eli Lilly (LLY) Amid Several Acquisition DealsYahoo Finance·Apr 29, 2026
- Forget Weight Loss Drugs: Here's An Even Better Reason to Invest in Eli LillyThe Motley Fool·Apr 28, 2026
- Is This $6.3 Billion Deal a Game Changer for Eli Lilly?Motley Fool·Apr 16, 2026
- Here Are Monday’s Top Wall Street Analyst Research Calls: Adobe, Best Buy, Bilibili, Constellation Brands, CoreWeave, Nike, Starbucks, T-Mobile, and More247 Wall St·Apr 13, 2026
- Looks Like M&A Week in 3 Different SectorsThe Motley Fool·Apr 8, 2026
- Pharma, Biotech Giants Ramp Up M&A in Q1 to Boost PipelinesYahoo Finance·Apr 6, 2026
- Eli Lilly Obesity Pill Approval And Sleep Deal Reshape Growth StoryYahoo Finance·Apr 5, 2026
- Jim Cramer Believes Eli Lilly’s “Weight Loss Pill Will Be a Blockbuster”Yahoo Finance·Apr 4, 2026
- Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers BankruptcyBenzinga·Apr 3, 2026
- Lilly’s Next Empire: A $10 Billion Bet on AI and NeuroscienceInvesting.com·Apr 2, 2026
- Lilly's Next Empire: A $10 Billion Bet on AI and NeuroscienceMarketbeat·Apr 2, 2026
- Eli Lilly (LLY) to Acquire Centessa Pharmaceuticals in $7.8B DealYahoo Finance·Apr 2, 2026
- Eli Lilly (LLY) Stock Trades Up, Here Is WhyYahoo Finance·Apr 2, 2026
- LLY to Buy Neuroscience Biotech Centessa Pharmaceuticals in $7.8B DealYahoo Finance·Apr 1, 2026
- Disney upgraded, Nike downgraded: Wall Street's top analyst callsYahoo Finance·Apr 1, 2026
- Here Are Wednesday’s Top Wall Street Analyst Research Calls: Boeing, Datadog, Disney, Formula One Group, Nike, Rivian, Rocket Lab, ServiceNow, and More247 Wall St·Apr 1, 2026
- Eli Lilly outlays $7.8bn to acquire sleep drug biotech CentessaPharmaceutical-technology·Apr 1, 2026
- Alkermes (ALKS) Nears 52-Week High on Increasing Orexin Receptor Market InterestYahoo Finance·Apr 1, 2026
- Centessa (CNTA) Soars to All-Time High on 38% Upside from Eli Lilly MergerYahoo Finance·Apr 1, 2026
- Why Centessa Stock Soared TodayMotley Fool·Apr 1, 2026
- Nxera Pharma's Partner Centessa Pharmaceuticals to be Acquired by LillyBenzinga·Mar 31, 2026
- Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by LillyGlobeNewswire Inc.·Mar 31, 2026
- Eli Lilly Expands Into Sleep Medicine With Centessa BuyoutBenzinga·Mar 31, 2026
All 27 articles loaded
Price Data
Open$39.70
Previous Close$39.67
Day High$39.75
Day Low$39.60
52 Week High$40.26
52 Week Low$10.95
52-Week Range
$10.95$40.26
$39.60
Fundamentals
Market Cap$6.1B
P/E Ratio—
EPS$-1.78
Dividend Yield—
Dividend / Share—
ROE-0.6%
Profit Margin—
Debt / Equity—
Trading
Volume874K
Avg Volume (10D)—
Shares Outstanding154.7M
About Centessa Pharmaceuticals plc
Centessa Pharmaceuticals Limited, a pharmaceutical company, develops and delivers drugs that change and improve the lives of patients. The company is headquartered in Cambridge, the United Kingdom.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—